ClariVest Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$596K Hold
7,255
0.06% 337
2024
Q2
$596K Buy
7,255
+2,375
+49% +$257K 0.06% 337
2024
Q1
$707K Buy
+4,880
New +$412K 0.07% 325

Other funds holding CDLX

ClariVest Asset Management's CDLX Position: Q3 2024 in Review

ClariVest Asset Management held its Cardlytics (CDLX) position steady in Q3 2024 at 7,255 shares worth $596K. The position accounts for 0.06% of the portfolio, ranked #337.

ClariVest Asset Management first reported a position in CDLX in Q1 2024 and has held it in 3 quarters since. The position peaked at $707K in Q1 2024. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • ClariVest Asset Management held 7,255 shares of Cardlytics worth $596K as of Q3 2024.
  • ClariVest Asset Management left its Cardlytics share count unchanged in Q3 2024.
  • Cardlytics made up 0.06% of ClariVest Asset Management's portfolio in Q3 2024, its #337 holding.
  • ClariVest Asset Management first reported a position in Cardlytics in Q1 2024 and has held it in 3 quarters since.
  • ClariVest Asset Management's Cardlytics position peaked at $707K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.